Navigation Links
BODY WORLDS 2 & Breathe California Pair Up for Some 'Ash Kicking'
Date:11/6/2007

Exhibit and special initiatives encourage smokers to say 'I Quit' at The

Tech Museum of Innovation

SILICON VALLEY, Calif., Nov. 6 /PRNewswire/ -- There's some 'ash-kicking' going on at the BODY WORLDS exhibit. Lung Cancer Awareness Month activities are in full swing at BODY WORLDS with Breathe California's 6-session Ash Kickers Quit Smoking Class and BODY WORLDS' I Quit smoking cessation program.

Every Thursday from now to December 13 at The Tech Museum of Innovation, (with the exception of Thanksgiving Day), Breathe California will host free smoking cessation. Classes will utilize group support and offer participants resources and strategies to quit and stay quit.

"Those who visit BODY WORLDS 2 can literally see the damage that smoking inflicts on your body. By bringing our stop-smoking class to The Tech, we will be able to offer assistance to those visitors who are inspired to quit," said Margo Sidener, President and CEO of Breathe California of the Bay Area.

Simultaneously, BODY WORLDS 2 is launching I Quit, which will run through the duration of the exhibition. BODY WORLDS conceived I Quit in 2006 when cleaning crews kept finding unfinished packs of cigarettes discarded on the glass display case containing the smoker's lungs.

The awareness initiative features an inspirational multimedia installation including late actor Yul Brynner's memorable anti-smoking PSA from the 1980s, pledge cards for visitors intending to give up smoking, a repository where visitors can leave their last packs of cigarettes, and take-home information.

"Each rejected pack marked a victory by one person against nicotine addiction," says Dr. Angelina Whalley, a physician and designer of the BODY WORLDS exhibitions. "Many visitors to the exhibition reported to us that they had tried everything to quit smoking but only stopped after seeing the smoker's lung on display."

"It is encouraging to see how many people are rea
'/>"/>

SOURCE BODY WORLDS
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine news :

1. Accordions Breathe Easier Since Smoking Ban
2. Hundreds to Gather for Rally in Celebration of Right to Breathe Clean Air
3. BREATHE Lung Cancer Conference, Nov. 30, Attracts World Renowned Physicians and Speakers
4. Wildlife Sightings on the Rise in California
5. AARP Poll: California Members Want Health Care Reform THIS YEAR
6. Author Kris Carr to Sign Crazy Sexy Cancer Tips at Two Borders(R) Stores in California
7. Hundreds of RNs from Across U.S. and World to Join California Nurses Association/NNOC National Convention
8. Karen Vigil Named Senior Vice President and Chief Executive Officer, Blue Shield of Californias Individual, Small Group, and Government Business Unit
9. NNN Healthcare/Office REIT Acquires St. Mary Physicians Center in Long Beach, California
10. Eight Graduate Nursing Students Selected to Receive The California Endowment-AACN Minority Nurse Faculty Scholarship
11. Blue Shield of California Names Vincent Coppola Vice President of Strategy and Business Development
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/21/2008)...y 21 /PRNewswire-FirstCall/ -- Aflac Incorporated,...presentation at the Sanford,C. Bernstein & Co., LL...nce,2008., President and Chief Financial Officer ...ted, and he is scheduled to make a presentation on...orated presentation, Mr.,Cloninger will discuss th...
(Date:5/21/2008)...d SILVER SPRING, Md., May 21 /PRNewswire-USNewswir... (ADAA),( http://www.adaa.org ) and The HealthCent... announced that ADAA will join,HealthCentral,s gro...and,health experts dedicated to helping people suf... advice and support they need to cope with the,con...
(Date:5/21/2008)...s 1st quarter profit, enhanced operations and new ...ELES, May 21 /PRNewswire-FirstCall/ -- InstaCare C...butor of at-home testing diagnostics,for the chron...eveloper of,patent-pending technologies for e-heal...s for the first quarter period-ended March 31, 200...
(Date:5/21/2008)... Adverse Events in TORCH Showed Frequency Highest ...ONTO and RESEARCH TRIANGLE PARK, N.C., May 21 /PRN...500/50 (fluticasone propionate and,salmeterol inha...er of,cardiovascular adverse events compared to ot...from the TOwards a Revolution in COPD Health,(TORC...
Breaking Medicine News(10 mins):Health News:Aflac Incorporated to Present at the Sanford C. Bernstein & Co., LLC Twenty-Fourth Annual Strategic Decisions Conference 2008 2Health News:The Anxiety Disorders Association of America and The HealthCentral Network Form Alliance to Develop New Online Resources for Anxiety Disorders 2Health News:The Anxiety Disorders Association of America and The HealthCentral Network Form Alliance to Develop New Online Resources for Anxiety Disorders 3Health News:InstaCare Corp. in Turnaround Reports 258% Revenues Increase in 1Q 2008 2Health News:InstaCare Corp. in Turnaround Reports 258% Revenues Increase in 1Q 2008 3Health News:InstaCare Corp. in Turnaround Reports 258% Revenues Increase in 1Q 2008 4Health News:InstaCare Corp. in Turnaround Reports 258% Revenues Increase in 1Q 2008 5Health News:Three-Year COPD Study Found No Increase in Cardiac Events With Advair(R) 500/50 2Health News:Three-Year COPD Study Found No Increase in Cardiac Events With Advair(R) 500/50 3
...lls, and AIDS/HIV is also one of them. It is obser...ed till the secondary levels show a// tendency to ...jumping at the first opportunity. The educated lot...rotected sex, according to a novel report on HIV. ...
...en on weight loss programmes, aspiring to melt awa...lulite is extremely obstinate// and never really g...New research has indicated that when women knock o...te actually makes the skin look worse. Cellulite h...
... share many characteristics with normal stem cells...oting tumor blood vessel// formation, and may hold...rch team reported in the August 15th issue of Canc..., associate professor at the Preston Robert Tisch ...
... University published his findings on a better sub..., this month//. According to peer-reviewed researc...it the kind of immune response doctors were lookin...esting, the vaccine was given to 100 volunteers at...
Other Medicine News:Health News:Cancer Stem Cells Could Hold Key to Brain Tumor Therapy 2
(Date:5/21/2008)...ark Laboratories, L.C., a,privately-owned biopharm...of enrollment into its Phase II clinical trial to ...n combination with standard of care therapy in,U.S... have previously,failed to respond to the standard...e company expects to announce interim data results...
(Date:5/21/2008)...oup of Leading Cancer Centers ...y 21 /- Endocare, Inc.,(Nas... focused on the,development of minimally invasive ... radiologists for tissue and tumor ablation, annou... method of freezing cancerous tumors,to destroy th...
(Date:5/20/2008)...positive results of nine month,PAINT trials for Dr...esults unveiled during plenary session of Eu...wswire/ -- Sahajanand Medical Technologies,Pvt. Lt...facturer of,drug-eluting stents, welcomed the posi...onths results of PAINT trial (PercutAneous INTerve...
(Date:5/20/2008)...igestive Disease Week -, CAMBRIDGE, Mass. and NEW...harmaceuticals, Inc. (formerly Microbia, Inc.) and...ounced the presentation of data,from a Phase 2b ra...ssessing the safety and efficacy of linaclotide in... of these data indicate that linaclotide met its,p...
Breaking Medicine Technology:Romark Laboratories Completes Enrollment in U.S. Phase II Study of Nitazoxanide for Chronic Hepatitis C Genotype 1 Non-Responders 2Romark Laboratories Completes Enrollment in U.S. Phase II Study of Nitazoxanide for Chronic Hepatitis C Genotype 1 Non-Responders 3Cryoablation Is Focus of 17 Clinical Studies at American Urological Association Annual Meeting 2Cryoablation Is Focus of 17 Clinical Studies at American Urological Association Annual Meeting 3Cryoablation Is Focus of 17 Clinical Studies at American Urological Association Annual Meeting 4Sahajanand Medical Technologies PAINT Trial Results Support Safety and Efficacy of the Infinnium and Supralimus Stents 2Sahajanand Medical Technologies PAINT Trial Results Support Safety and Efficacy of the Infinnium and Supralimus Stents 3Ironwood Pharmaceuticals and Forest Laboratories Announce Presentation of Linaclotide Phase 2b Chronic Constipation Study Results 2Ironwood Pharmaceuticals and Forest Laboratories Announce Presentation of Linaclotide Phase 2b Chronic Constipation Study Results 3Ironwood Pharmaceuticals and Forest Laboratories Announce Presentation of Linaclotide Phase 2b Chronic Constipation Study Results 4Ironwood Pharmaceuticals and Forest Laboratories Announce Presentation of Linaclotide Phase 2b Chronic Constipation Study Results 5Ironwood Pharmaceuticals and Forest Laboratories Announce Presentation of Linaclotide Phase 2b Chronic Constipation Study Results 6Secondhand smoke increases teen test failure 1648 1Secondhand smoke increases teen test failure 1648 2Spectral partner launches EAA 28TM 29 Rapid Sepsis Diagnostic in Germany 711 1Spectral partner launches EAA 28TM 29 Rapid Sepsis Diagnostic in Germany 711 2Vical Licensee Sanofi aventis Initiates Phase 3 Trial to Reduce Amputations 336 1Vical Licensee Sanofi aventis Initiates Phase 3 Trial to Reduce Amputations 336 2Vical Licensee Sanofi aventis Initiates Phase 3 Trial to Reduce Amputations 336 3MedAire to Provide Medical Training for Bombardier Safety Standdown 1644 1MedAire to Provide Medical Training for Bombardier Safety Standdown 1644 2MedAire to Provide Medical Training for Bombardier Safety Standdown 1644 3
...ylene Glycol,(DEG) Remains a Potential Health Haza...he U.S. Food and Drug,Administration (FDA) is warn...repackers, and health professionals who compound,m...hat glycerin, a,sweetener commonly used worldwide ...roducts, is not contaminated with diethylene,glyco...
...nnovations and a Health Conscious,Public?, WASHING... Food,and Drug Administration (FDA) must adapt to ...lthcare, Commissioner Andrew von,Eschenbach told a...,Annual Conference April 12 in Bethesda, Md. , FDA...ited,financial and personnel resources to deal wit...
Other Medicine Technology:FDA Advises Manufacturers to Test Glycerin for Possible,Contamination 2FDLI 50th Annual Meeting Heralds New ERA in Healthcare Innovations,FDA Regulations 2
Cushing bayonet forceps. Insulated.
Scleral blades designed for trabeculectomy and groove type incisions, scleral standard USA size.
Accurately tests for Nystagmus when rotated at 8-10 rpm. Drums are 10" high by 8" diameter. Light weight drum of professional quality with ball bearings for effortless spin mechanism. For use 24 to 3
Diagnose dry eye, assess the effectiveness of permanent punctal occlusion, collagen - dissolvable in 3-5 days, all are 2 mm long. Sterile
Medicine Products: